Recently, Jiang et al. [42] developed immune‐based classification (Immunoscore), a prediction model for GC patients using CD3 IF, CD3 IT, CD8 IF, CD45RO IT, and CD66b IF data from 879 consecutive patients. This evidence concerns the gene CD8A and gastric cancer.